Emerging biomarkers in thyroid practice and research
Simple Summary Tumor biomarkers are molecules at genetic or protein level, or certain
evaluable characteristics. These help in perfecting patient management. Over the past …
evaluable characteristics. These help in perfecting patient management. Over the past …
[HTML][HTML] Prevalence of BRAFV600E mutation in Asian series of papillary thyroid carcinoma—a contemporary systematic review
Papillary thyroid carcinoma (PTC), the most common malignancy of the endocrine system, is
frequently driven by BRAF V600E mutation, which was reported in 35–60% cases in …
frequently driven by BRAF V600E mutation, which was reported in 35–60% cases in …
PD-L1 expression and its modulating factors in anaplastic thyroid carcinoma: a multi-institutional study
Anti-PD immunotherapy is currently under investigation in anaplastic thyroid carcinoma
(ATC). Tumor cell surface PD-L1 expression is considered predictive of therapeutic …
(ATC). Tumor cell surface PD-L1 expression is considered predictive of therapeutic …
CD73 overexpression promotes progression and recurrence of papillary thyroid carcinoma
YM Jeong, H Cho, TM Kim, Y Kim, S Jeon, A Bychkov… - Cancers, 2020 - mdpi.com
Simple Summary This study aimed to evaluate the clinicopathologic significance of CD73
expression in patients with papillary thyroid carcinoma (PTC) and the potential for CD73 to …
expression in patients with papillary thyroid carcinoma (PTC) and the potential for CD73 to …
[HTML][HTML] Molecular correlates and nuclear features of encapsulated follicular-patterned thyroid neoplasms
Background Assessing nuclear features is diagnostically challenging in the aspect of thyroid
pathology. The aim of this study was to determine whether pathologists could distinguish …
pathology. The aim of this study was to determine whether pathologists could distinguish …
Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid pathology
Introduction Despite advancements in diagnostic methods, the classification of
indeterminate thyroid nodules still poses diagnostic challenges not only in pre-surgical …
indeterminate thyroid nodules still poses diagnostic challenges not only in pre-surgical …
Comparative efficiency of differential diagnostic methods for the identification of BRAF V600E gene mutation in papillary thyroid cancer
Q Liu, X Jiang, W Tu, L Liu… - Experimental and …, 2024 - spandidos-publications.com
V‑Raf murine sarcoma viral oncogene homolog B1 (BRAF) encodes a serine‑threonine
kinase. The V600E point mutation in the BRAF gene is the most common mutation …
kinase. The V600E point mutation in the BRAF gene is the most common mutation …
VE1 immunohistochemistry is an adjunct tool for detection of BRAFV600E mutation: Validation in thyroid cancer patients
Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy among other
endocrine tumors, and BRAFV600E is a frequent genetic mutation occurring in the disease …
endocrine tumors, and BRAFV600E is a frequent genetic mutation occurring in the disease …
Prognostic Value of LINC-ROR (rs1942347) Variant in Patients with Colon Cancer Harboring BRAF Mutation: A Propensity Score-Matched Analysis
Emerging studies show that long intergenic non-protein coding RNA, regulator of
reprogramming (LINC-ROR) is aberrantly expressed in several types of cancer, including …
reprogramming (LINC-ROR) is aberrantly expressed in several types of cancer, including …
Prognostic implications of CD10 and CD15 expression in papillary thyroid carcinoma
Patients with papillary thyroid carcinoma (PTC) have excellent survival, but recurrence
remains a major problem in the management of PTC. We aimed to determine the prognostic …
remains a major problem in the management of PTC. We aimed to determine the prognostic …